A lab on UNLV’s campus has been a hub of activity in recent years, playing a significant role in a new realm of drug discovery — one that could potentially provide a solution for patients who have run out of options.
A new program in Biotechnology and Health Economics at Rensselaer Polytechnic Institute will equip students destined for a science-based career with the quantitative and modeling knowledge in economics needed to succeed in industry and consulting.
As the world rushes to identify safe and effective vaccines and therapeutics to counter the COVID-19 epidemic, attention is turning to the next step: manufacturing these products at enormous scale.
MADISON, Wis. — U.S. hospitals wait over a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs. A survey of how 132 hospitals prescribed six new…